Four days after hearing oral arguments in a challenge to the constitutionality of a task force within the Department of Health and Human Services, the Supreme Court asked both the federal government ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. The candidate fell short in a phase 2 psoriasis trial, prompting the French drugmaker to pull back from plans to ...

Image credit: Shutterstock / LCV Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as a monotherapy after it failed to reach the primary endpoint in a ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical data. The latest results show a high starting dose, fast titration model ...

Ascletis is hoping to initiate a Phase IIa trial in the US in Q3 2025. Image credit: Shutterstock / Pixel-Shot Ascletis has announced its oral glucagon-like peptide-1 receptor agonist (GLP-1RA) has ...

During oral arguments Tuesday, most of the justices on the U.S. Supreme Court appeared sympathetic toward parents in their lawsuit against a Maryland school board that refused to let them opt ...

Gut health is a buzzy topic, but the oral microbiome might be the next big trend. The evidence that a clean mouth could lower the risk of chronic diseases is piling up. Big voices in the longevity ...